直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Ad Law Buzz Blog

“Banning” a Banned Ingredients Claim: NAD’s Application (and Expansion) of the FTC’s Green Guides

March 18, 2024

Authored and Edited by Jennifer E. Fried

In its recent Biossance decision, NAD found fault with the advertiser’s claim that its cosmetics contain “Clean ingredients and clean formulas—we ban over 2000 ingredients that are known to be toxic to you and the environment.”

The basis of NAD’s recommendation to modify this claim serves as an important reminder to advertisers making claims about what is not found in their products.

Key Takeaways

    • When making claims about “banned” substances, consider industry norms
    • Avoid “banned” or “free of” claims where the substance at issue is not found in competing products
    • Even monadic (non-comparative) claims can present risk of a competitive challenge, especially where the claim creates an implied message about the composition of competing products.


In recommending that this “ban over 2000 ingredients” claim be modified, NAD relied—as it often does—on the FTC’s Green Guides. These Guides provide guardrails for advertisers that wish to make certain environmental claims, including the claims that a product is “free from” any given substance. Among other restrictions, the FTC notes that such “free” claims are not permissible where “the substance is not associated with the product category” to begin with. (A toilet paper cannot be “free from” shards of glass because toilet paper does not normally contain glass. Potato chips cannot be “free from” horse manure because chips do not normally contain manure.)

NAD applied this well-established rule in its Biossance decision, noting that there is “no information in the record as to which of these ingredients that are on the banned lists are typically used as cosmetic ingredients.” In other words, NAD did not question that the advertiser banned over 2000 ingredients. Nor did NAD question the toxicity of the banned ingredients. The basis of NAD’s recommendation, rather, was that many of these “banned” ingredients were not found in cosmetic products as a general matter.

NAD’s Biossance decision was the latest in a string of recent NAD cases that reiterate the FTC’s “free from” guidance. Last year, for example, NAD found fault with a “no aluminum” claim that appeared on deodorant on the grounds that deodorants, by definition, do not contain aluminum. The year prior, NAD recommended the discontinuation of “plastic free” claims made in association with chewing gum. There, the self-regulatory system found the claim to be deceptive because plastic is not normally associated with chewing gum.

Here, NAD went one step further by applying its and the FTC’s long-held “free from” guidance to a slightly different sort of claim: the statement that “we ban” certain ingredients. NAD’s application of the Guides to the “we ban” claim in Biossance is a reminder that NAD can and will invoke FTC guidance beyond the Guides’ black letter. While touting “banned” ingredients seems intuitively on par with making “free from” claims, this small expansion of FTC’s “free from” guidance is a reminder that any claims expressly or impliedly touting a substance’s absence may be subject to the Green Guides.

Tags

cosmetics, false advertising

Related Practices

Trademark and Brand Management

Advertising

Related Industries

Consumer Goods and Services

Consumer Products

Life Sciences

Related Offices

Washington, DC

Contacts

Jennifer E. Fried
Partner
Washington, DC
+1 202 408 4166
Email

Copyright © 2024 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Reception

2026 IPO Education Foundation Awards Dinner

December 15, 2026

Washington, DC

Conference

IP Life Sciences Forum 2026

December 13-15, 2026

Coral Gables

Panel Discussion

2026 Advanced Patent Law Institute

December 3-4, 2026

Stanford

Conference

IPBC Asia 2026

November 17-19, 2026

Tokyo

Conference

IAM Live: Trade Secret Strategy USA

November 10, 2026

San Jose

Charitable

2026 ALYN Hospital Wheels of Love Ride

November 8-12, 2026

Northern District

Conference

IAM Live: Navigating the UPC 2026

November 4, 2026

Paris

Conference

2026 ANA Masters of Advertising Law Conference

November 2-4, 2026

Huntington Beach

Conference

Life Sciences Patent Network North America Fall 2026

November 2-3, 2026

San Francisco

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP